神经功能完好的轻型创伤性颅内出血是否需要逆转抗凝?
本研究为回顾性队列研究,利用2018至2021年35家创伤中心数据,纳入654例伤前使用抗凝药、钝性创伤致颅内出血且GCS 15分的患者,比较逆转与未逆转抗凝的院内结局。结果显示两组院内死亡或临终关怀率及并发症无差异,提示此类神经功能完好患者或无需逆转抗凝。
要点
- 神经功能完好的轻型创伤性颅内出血患者逆转抗凝未改善院内结局。
- 逆转组与未逆转组院内死亡或临终关怀率分别为4.6%与4.91%,无统计学差异。
- 需进一步研究明确哪些创伤性颅内出血患者可不必逆转抗凝。
核心结论
- 神经功能完好的口服抗凝药相关轻型创伤性颅内出血患者,逆转抗凝与未逆转的院内结局无差异。
研究设计与样本
- 回顾性队列研究,利用2018至2021年35家创伤中心数据,纳入654例伤前使用抗凝药、钝性创伤致颅内出血、GCS 15分且AIS头部分2至4分的患者。
主要发现
- 逆转组院内死亡或临终关怀12例(4.6%),未逆转组19例(4.91%),p=0.861。
- 逆转组医院并发症复合终点21例(8%),未逆转组34例(8.7%),p=0.748。
- 逆转组ICU平均住院时长1.4±3.4天,未逆转组1.1±1.8天,p=0.069。
临床怎么用
- 对于神经功能完好、GCS 15分的轻型创伤性颅内出血且伤前使用抗凝药的患者,可考虑不逆转抗凝,但需结合个体情况评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Falls are the leading cause of injury in older individuals, with intracranial hemorrhage (ICH) being a common complication. Anticoagulants, such as vitamin K antagonist and direct oral anticoagulants, are increasingly utilized, and clinicians may question the necessity of reversal in patients with minor ICH, especially in the setting of increased risk of adverse events. This study aimed to identify a population of patients with minor traumatic ICH at low risk for poor-neurologic status where anticoagulant reversal may not improve outcomes. METHODS: This retrospective cohort study utilized data accessed from 35 trauma centers from 2018 to 2021. Patients included had a preinjury anticoagulant regimen, ICH due to blunt trauma, Glasgow Coma Scale score of 15, an Abbreviated Injury Scale (AIS) head score from 2 to 4, and an AIS of ≤1 for non-head regions within 24 h of hospital arrival. Patients were excluded if they required an emergent neurosurgical procedure or were on a preinjury purinergic-P2 receptor-12 protein (P2Y12) inhibitor. The primary outcome was the rate of in-hospital mortality or hospice. RESULTS: There were 654 patients on preinjury anticoagulation who were included with a minor traumatic ICH without neurologic deficits. Overall, 263 patients were reversed and 391 were not reversed. Twelve (4.6%) patients with in-hospital mortality or hospice were reversed compared with 19 (4.91%) patients who were not reversed (p = 0.861). A composite of hospital complications occurred in 21 (8%) reversed patients and 34 (8.7%) not reversed patients (p = 0.748). The average intensive care unit length of stay was 1.4 ± 3.4 days in the reversed group and 1.1 ± 1.8 days in the not reversed group (p = 0.069). CONCLUSION: This study found no difference in hospital outcomes between patients with minor traumatic ICH on oral anticoagulants who were neurologically intact that were reversed versus those who were not reversed. Further studies should continue to define the subset of traumatic ICH patients who may not require reversal of anticoagulation.
引用
- Powell K, Curtiss W, Sadek E, et al. Is reversal of anticoagulants necessary in neurologically intact traumatic intracranial hemorrhage? Pharmacotherapy. 2024. PMID: 38140830. doi:10.1002/phar.2901
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。